Literature DB >> 25157083

CcpA-mediated catabolite activation of the Bacillus subtilis ilv-leu operon and its negation by either CodY- or TnrA-mediated negative regulation.

Yasutaro Fujita1, Takenori Satomura2, Shigeo Tojo2, Kazutake Hirooka2.   

Abstract

The Bacillus subtilis ilv-leu operon functions in the biosynthesis of branched-chain amino acids. It undergoes catabolite activation involving a promoter-proximal cre which is mediated by the complex of CcpA and P-Ser-HPr. This activation of ilv-leu expression is negatively regulated through CodY binding to a high-affinity site in the promoter region under amino acid-rich growth conditions, and it is negatively regulated through TnrA binding to the TnrA box under nitrogen-limited growth conditions. The CcpA-mediated catabolite activation of ilv-leu required a helix face-dependent interaction of the complex of CcpA and P-Ser-HPr with RNA polymerase and needed a 19-nucleotide region upstream of cre for full activation. DNase I footprinting indicated that CodY binding to the high-affinity site competitively prevented the binding of the complex of CcpA and P-Ser-HPr to cre. This CodY binding not only negated catabolite activation but also likely inhibited transcription initiation from the ilv-leu promoter. The footprinting also indicated that TnrA and the complex of CcpA and P-Ser-HPr simultaneously bound to the TnrA box and the cre site, respectively, which are 112 nucleotides apart; TnrA binding to its box was likely to induce DNA bending. This implied that interaction of TnrA bound to its box with the complex of CcpA and P-Ser-HPr bound to cre might negate catabolite activation, but TnrA bound to its box did not inhibit transcription initiation from the ilv-leu promoter. Moreover, this negation of catabolite activation by TnrA required a 26-nucleotide region downstream of the TnrA box.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25157083      PMCID: PMC4248793          DOI: 10.1128/JB.02055-14

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

1.  Purification and in vitro activities of the Bacillus subtilis TnrA transcription factor.

Authors:  L V Wray; J M Zalieckas; S H Fisher
Journal:  J Mol Biol       Date:  2000-06-30       Impact factor: 5.469

2.  Bacillus subtilis glutamine synthetase controls gene expression through a protein-protein interaction with transcription factor TnrA.

Authors:  L V Wray; J M Zalieckas; S H Fisher
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

3.  Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis.

Authors:  Virginie Molle; Yoshiko Nakaura; Robert P Shivers; Hirotake Yamaguchi; Richard Losick; Yasutaro Fujita; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

4.  Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.

Authors:  Takenori Satomura; Daisuke Shimura; Kei Asai; Yoshito Sadaie; Kazutake Hirooka; Yasutaro Fujita
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS.

Authors:  C Anagnostopoulos; J Spizizen
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

6.  CodY is required for nutritional repression of Bacillus subtilis genetic competence.

Authors:  P Serror; A L Sonenshein
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

7.  CcpA forms complexes with CodY and RpoA in Bacillus subtilis.

Authors:  Andrea Wünsche; Elke Hammer; Maike Bartholomae; Uwe Völker; Andreas Burkovski; Gerald Seidel; Wolfgang Hillen
Journal:  FEBS J       Date:  2012-05-21       Impact factor: 5.542

8.  Elaborate transcription regulation of the Bacillus subtilis ilv-leu operon involved in the biosynthesis of branched-chain amino acids through global regulators of CcpA, CodY and TnrA.

Authors:  Shigeo Tojo; Takenori Satomura; Kaori Morisaki; Josef Deutscher; Kazutake Hirooka; Yasutaro Fujita
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

Review 9.  Carbon catabolite control of the metabolic network in Bacillus subtilis.

Authors:  Yasutaro Fujita
Journal:  Biosci Biotechnol Biochem       Date:  2009-02-07       Impact factor: 2.043

10.  Streptococcal phosphoenolpyruvate: sugar phosphotransferase system: purification and characterization of a phosphoprotein phosphatase which hydrolyzes the phosphoryl bond in seryl-phosphorylated histidine-containing protein.

Authors:  J Deutscher; U Kessler; W Hengstenberg
Journal:  J Bacteriol       Date:  1985-09       Impact factor: 3.490

View more
  5 in total

1.  NanI Sialidase, CcpA, and CodY Work Together To Regulate Epsilon Toxin Production by Clostridium perfringens Type D Strain CN3718.

Authors:  Jihong Li; John C Freedman; Bruce A McClane
Journal:  J Bacteriol       Date:  2015-08-10       Impact factor: 3.490

Review 2.  Branching Out: Alterations in Bacterial Physiology and Virulence Due to Branched-Chain Amino Acid Deprivation.

Authors:  Julienne C Kaiser; David E Heinrichs
Journal:  MBio       Date:  2018-09-04       Impact factor: 7.867

3.  Characterization of LrgAB as a stationary phase-specific pyruvate uptake system in Streptococcus mutans.

Authors:  Sang-Joon Ahn; Kamal Deep; Matthew E Turner; Ivan Ishkov; Anthony Waters; Stephen J Hagen; Kelly C Rice
Journal:  BMC Microbiol       Date:  2019-10-12       Impact factor: 3.605

4.  The CodY regulator is essential for virulence in Streptococcus suis serotype 2.

Authors:  Liping Feng; Jiawen Zhu; Haitao Chang; Xiaoping Gao; Cheng Gao; Xiaofeng Wei; Fangyan Yuan; Weicheng Bei
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

5.  Regulation of cid and lrg expression by CodY in Streptococcus mutans.

Authors:  Sang-Joon Ahn; Hey-Min Kim; Shailja Desai; Kamal Deep; Kelly C Rice
Journal:  Microbiologyopen       Date:  2020-04-13       Impact factor: 3.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.